FFCP PHASE1:Hg19::chr8:130560794..130560810,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr8:130560794..130560810,- | |||
|coexpression_cluster_id=C1286 | |||
|description=CAGE_peak_at_chr8:130560794..130560810,- | |||
|id=chr8:130560794..130560810,- | |||
|ontology_enrichment_celltype=CL:0000763!9.87e-23!112;CL:0000049!9.87e-23!112;CL:0002032!2.48e-21!165;CL:0000837!2.48e-21!165;CL:0000037!3.93e-20!172;CL:0000566!3.93e-20!172;CL:0000988!1.41e-18!182;CL:0000557!1.64e-07!71;CL:0002009!3.58e-07!65;CL:0002031!7.65e-07!124 | |||
|ontology_enrichment_celltype_v019=CL:0000763;8.76e-11;100!CL:0000946;1.76e-09;1!CL:0000786;1.76e-09;1!CL:0002127;1.99e-09;1!CL:0000911;1.99e-09;1!CL:0000814;1.99e-09;1!CL:0002032;5.07e-09;1!CL:0000817;5.07e-09;1!CL:0000557;5.07e-09;1 | |||
|ontology_enrichment_celltype_v019_2=CL:0002032,2.88e-20,161;CL:0000837,2.88e-20,161;CL:0000037,2.82e-19,168;CL:0000763,3.09e-18,108;CL:0000049,3.09e-18,108;CL:0000988,4.07e-18,177;CL:0000817,1.87e-11,3;CL:0000946,1.84e-09,1;CL:0000786,1.84e-09,1;CL:0000980,1.84e-09,1;CL:0002127,1.99e-09,1;CL:0000914,1.99e-09,1;CL:0000911,1.99e-09,1;CL:0000814,1.99e-09,1;CL:0002042,1.99e-09,1;CL:0002039,1.99e-09,1;CL:0002040,1.99e-09,1;CL:0002041,1.99e-09,1;CL:0000134,3.44e-07,354;CL:0002320,5.65e-07,361 | |||
|ontology_enrichment_development_v019=CL:0000049;1.66e-07;108 | |||
|ontology_enrichment_disease=DOID:8692!7.61e-39!31;DOID:1240!2.21e-37!39;DOID:2531!1.13e-33!51;DOID:0060083!1.13e-33!51;DOID:0050686!5.20e-09!137 | |||
|ontology_enrichment_disease_v019=DOID:8692;8.91e-61;31!DOID:1240;8.80e-48;39!DOID:2531;7.49e-34;51!DOID:0060083;7.49e-34;51!DOID:225;1.03e-09;1!DOID:630;3.83e-09;1!DOID:0050177;3.83e-09;1!DOID:0050427;3.83e-09;1!DOID:8552;5.07e-09;1!DOID:0050686;2.80e-07;137 | |||
|ontology_enrichment_disease_v019_2=DOID:8692,1.97e-63,31;DOID:1240,2.58e-63,39;DOID:2531,2.35e-59,51;DOID:0060083,2.35e-59,51;DOID:0050686,8.12e-20,137;DOID:162,4.00e-10,235;DOID:14566,7.70e-10,239;DOID:225,1.03e-09,1;DOID:630,3.83e-09,1;DOID:0050177,3.83e-09,1;DOID:0050427,3.83e-09,1;DOID:8552,5.28e-09,1 | |||
|ontology_enrichment_uberon=UBERON:0002390!4.76e-07!102;UBERON:0003061!4.76e-07!102 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.200544447470142,0,0,0,0,0,0.377875943688809,0,0,0,0,0.28769239232215,0.512321413058201,0,0,0,0,0,0,0,0,0,0,0,0.199463657621632,0,0,0,0,0,0,0.434377689410233,0,0,0,0,0,0,0,0,0,0.570025487482497,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.324547393654683,0.174129737299267,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.49217205568284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.00988449083511,0,0,0,0,3.17510374085824,0,0,2.05411211129873,3.60363760277953,0,0,6.74469915435538,17.3547748184301,10.6461559422582,8.93113896364988,10.753426750796,4.2498460499559,9.34355193586688,4.68931428964897,0,0,1.6227340708559,0,4.22961015263549,0,0,0,0,0,0,0,0,0,0.140669416410513,0,2.96646973608167,0,0,0.276283915531148,0,0,0.123084805461069,0,0,0,7.1620131831762,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241192877250816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.16348177330109,0,0,0.167821586975843,0,0.635746315921515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136905378891993,1.27746588066972,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.2249738915515,0,0.0607495566580247,0,0,0,0,0,0,0,0,0,0,0,0,0,26.0233290775405,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1251909307065,0,0.110929051536852,0.124192805882767,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.6691729694141,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.39105503505389,0,0,0,0.0642292250964595,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.45310330312364,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.430227358820278,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.187967835959707,0,8.2951159417691,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.20686599172379,0,0,0,0,0,0,0,0.217716747896961,0,0,0,0,0,0,0,0,0,0.122241444182866,0,0,0,2.24397944612263 | |||
|short_description=p@chr8:130560794..130560810,- | |||
}} |
Latest revision as of 15:02, 31 July 2015
Short description: | p@chr8:130560794..130560810, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr8:130560794..130560810, - |
Coexpression cluster: | C1286_myelodysplastic_acute_leukemia_biphenotypic_CD14CD16_splenic_Dendritic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic oligopotent progenitor cell | 2.88e-20 | 161 |
hematopoietic multipotent progenitor cell | 2.88e-20 | 161 |
hematopoietic stem cell | 2.82e-19 | 168 |
myeloid cell | 3.09e-18 | 108 |
common myeloid progenitor | 3.09e-18 | 108 |
hematopoietic cell | 4.07e-18 | 177 |
precursor B cell | 1.87e-11 | 3 |
antibody secreting cell | 1.84e-09 | 1 |
plasma cell | 1.84e-09 | 1 |
plasmablast | 1.84e-09 | 1 |
innate effector T cell | 1.99e-09 | 1 |
immature NK T cell | 1.99e-09 | 1 |
effector T cell | 1.99e-09 | 1 |
mature NK T cell | 1.99e-09 | 1 |
immature NK T cell stage IV | 1.99e-09 | 1 |
immature NK T cell stage I | 1.99e-09 | 1 |
immature NK T cell stage II | 1.99e-09 | 1 |
immature NK T cell stage III | 1.99e-09 | 1 |
mesenchymal cell | 3.44e-07 | 354 |
connective tissue cell | 5.65e-07 | 361 |
Ontology term | p-value | n |
---|---|---|
myeloid leukemia | 1.97e-63 | 31 |
leukemia | 2.58e-63 | 39 |
hematologic cancer | 2.35e-59 | 51 |
immune system cancer | 2.35e-59 | 51 |
organ system cancer | 8.12e-20 | 137 |
cancer | 4.00e-10 | 235 |
disease of cellular proliferation | 7.70e-10 | 239 |
syndrome | 1.03e-09 | 1 |
genetic disease | 3.83e-09 | 1 |
monogenic disease | 3.83e-09 | 1 |
xeroderma pigmentosum | 3.83e-09 | 1 |
chronic myeloid leukemia | 5.28e-09 | 1 |